AVE avecho biotechnology limited

nutraceuticals looking good, page-3

  1. 5,324 Posts.
    Thankyou Hottod, another great post and one worthy of many TUs (which Im certain will occur as now seems the norm for your wonderful insights).

    This topic of Nutraceuticals really merits much more discussion. It will in my opinion become a major activity stream within the POH Pipeline and has the very real potential to produce huge returns for POH, her licencing partners and of course we shareholders.

    What many may not realise is that any POH Nutraceutical product will (unlike Pharma and Cosmetics)contain a very high % of TPM. In some cases the product will have TPM as the majority of its formulation. What does this mean to POH? Really BIG $$$$ to the bottom line!

    Im sure the potential for massive manufacturing revenues and profits from Nutracueticals has not been lost on the POH Board . As we know POH has flagged it expects to substantially grow revenues from the manufacture of TPM. Further the production costs for TPM are low and the production process and plant is scaleable and relactively inexpensive to grow capacity. I can only conclude that POH is very serious about Nutracueticals for Humans and Animals and it this new area of development that will underpin POHs expected growth in manufacturing revenues.
    These are just my views- so no need to throw brickbats- what does the brains trust think?

    KC
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $11.10M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $453 129.4K

Buyers (Bids)

No. Vol. Price($)
40 33486086 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8328117 7
View Market Depth
Last trade - 13.52pm 04/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.